Stock SFA SOPHARMA AD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sopharma AD

Equities

SFA

BG11SOSOBT18

Drug Retailers

End-of-day quote Bulgaria S.E.
Other stock markets
 18:00:00 2024-04-25 EDT 		5-day change 1st Jan Change
6.04 BGN +1.34% Intraday chart for Sopharma AD 0.00% +5.59%
02-29 Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 428.1 402.5 556.1 541.1 910.1 1,000
Enterprise Value (EV) 1 428.1 802.1 556.1 804.8 910.1 1,000
P/E ratio 4.93 x 16.1 x - 7.43 x 8.41 x 13.1 x
Yield - 1.25% - - 15.7% 4.97%
Capitalization / Revenue 0.33 x 0.28 x 0.35 x 0.33 x 0.49 x 0.5 x
EV / Revenue 0.33 x 0.28 x 0.35 x 0.33 x 0.49 x 0.5 x
EV / EBITDA - 4.44 x - 3.82 x 5.93 x 7.01 x
EV / FCF - -1,986,263 x - 5,977,813 x - -
FCF Yield - -0% - 0% - -
Price to Book - 0.73 x - 0.77 x - -
Nbr of stocks (in thousands) 125,916 125,769 124,686 121,319 159,112 165,622
Reference price 2 3.400 3.200 4.460 4.460 5.720 6.040
Announcement Date 20-04-29 21-03-01 22-01-31 23-03-01 24-02-29 -
1BGN in Million2BGN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 1,282 1,440 1,603 1,663 1,874 1,989
EBITDA 1 - 90.61 - 141.6 153.4 142.6
EBIT - 44 63.15 89.57 - -
Operating Margin - 3.06% 3.94% 5.39% - -
Earnings before Tax (EBT) - 25.39 - 87.03 - -
Net income 1 - 24.98 91.41 72.55 95.21 72.19
Net margin - 1.73% 5.7% 4.36% 5.08% 3.63%
EPS 2 0.6900 0.1990 - 0.6000 0.6800 0.4600
Free Cash Flow - -202.6 - 90.52 - -
FCF margin - -14.07% - 5.44% - -
FCF Conversion (EBITDA) - - - 63.91% - -
FCF Conversion (Net income) - - - 124.76% - -
Dividend per Share 2 - 0.0400 - - 0.9000 0.3000
Announcement Date 20-04-29 21-03-01 22-01-31 23-03-01 24-02-29 -
1BGN in Million2BGN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - 400 - 264 - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - 4.411 x - 1.862 x - -
Free Cash Flow - -203 - 90.5 - -
ROE (net income / shareholders' equity) - 4.5% - 10.7% 13.2% 8%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - 4.400 - 5.820 - -
Cash Flow per Share - 0.5100 - 0.8800 - -
Capex - 24.7 - 21.3 - -
Capex / Sales - 1.71% - 1.28% - -
Announcement Date 20-04-29 21-03-01 22-01-31 23-03-01 24-02-29 -
1BGN in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.04 BGN
Average target price
7.14 BGN
Spread / Average Target
+18.21%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
SOPHARMA AD Stock Sopharma AD
+5.59% 546M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. SFA Stock
  4. Financials Sopharma AD